Citigroup’s NRC Health Common Stock NRC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.2K | Buy |
659
+354
| +116% | +$6.02K | ﹤0.01% | 4992 |
|
|
2025
Q4 | $5.72K | Sell |
305
-2,335
| -88% | -$35.2K | ﹤0.01% | 5209 |
|
|
2025
Q3 | $33.7K | Sell |
2,640
-3,904
| -60% | -$58.5K | ﹤0.01% | 4618 |
|
|
2025
Q2 | $110K | Sell |
6,544
-5,340
| -45% | -$72.1K | ﹤0.01% | 4358 |
|
|
2025
Q1 | $152K | Sell |
11,884
-1,186
| -9% | -$19K | ﹤0.01% | 4347 |
|
|
2024
Q4 | $231K | Buy |
13,070
+1,959
| +18% | +$37.2K | ﹤0.01% | 4332 |
|
|
2024
Q3 | $254K | Buy |
11,111
+3,859
| +53% | +$87.2K | ﹤0.01% | 4179 |
|
|
2024
Q2 | $166K | Buy |
7,252
+1,162
| +19% | +$35.8K | ﹤0.01% | 3982 |
|
|
2024
Q1 | $241K | Buy |
6,090
+1,678
| +38% | +$66.4K | ﹤0.01% | 3919 |
|
|
2023
Q4 | $175K | Buy |
4,412
+3,296
| +295% | +$138K | ﹤0.01% | 3969 |
|
|
2023
Q3 | $49.5K | Sell |
1,116
-5,255
| -82% | -$229K | ﹤0.01% | 4142 |
|
|
2023
Q2 | $277K | Buy |
6,371
+4,279
| +205% | +$188K | ﹤0.01% | 3727 |
|
|
2023
Q1 | $91K | Buy |
2,092
+1,245
| +147% | +$55K | ﹤0.01% | 4054 |
|
|
2022
Q4 | $31.6K | Buy |
847
+123
| +17% | +$4.76K | ﹤0.01% | 4429 |
|
|
2022
Q3 | $29K | Sell |
724
-773
| -52% | -$28.6K | ﹤0.01% | 4602 |
|
|
2022
Q2 | $57K | Buy |
1,497
+30
| +2% | +$1.08K | ﹤0.01% | 4479 |
|
|
2022
Q1 | $59K | Sell |
1,467
-2,437
| -62% | -$95.4K | ﹤0.01% | 4655 |
|
|
2021
Q4 | $162K | Buy |
3,904
+2,008
| +106% | +$87.3K | ﹤0.01% | 4465 |
|
|
2021
Q3 | $80K | Buy |
1,896
+787
| +71% | +$39.6K | ﹤0.01% | 4501 |
|
|
2021
Q2 | $51K | Sell |
1,109
-108
| -9% | -$5.14K | ﹤0.01% | 4817 |
|
|
2021
Q1 | $57K | Sell |
1,217
-2,545
| -68% | -$124K | ﹤0.01% | 4633 |
|
|
2020
Q4 | $161K | Buy |
3,762
+915
| +32% | +$47K | ﹤0.01% | 5152 |
|
|
2020
Q3 | $140K | Sell |
2,847
-3,215
| -53% | -$178K | ﹤0.01% | 4867 |
|
|
2020
Q2 | $353K | Buy |
6,062
+2,117
| +54% | +$112K | ﹤0.01% | 4565 |
|
|
2020
Q1 | $179K | Buy |
3,945
+1,485
| +60% | +$89.2K | ﹤0.01% | 4828 |
|
|
2019
Q4 | $162K | Sell |
2,460
-1,507
| -38% | -$92.1K | ﹤0.01% | 5366 |
|
|
2019
Q3 | $229K | Buy |
3,967
+196
| +5% | +$12.1K | ﹤0.01% | 5048 |
|
|
2019
Q2 | $217K | Buy |
3,771
+422
| +13% | +$19.5K | ﹤0.01% | 5189 |
|
|
2019
Q1 | $129K | Buy |
3,349
+7
| +0.2% | +$274 | ﹤0.01% | 5510 |
|
|
2018
Q4 | $127K | Buy |
3,342
+489
| +17% | +$18.8K | ﹤0.01% | 5451 |
|
|
2018
Q3 | $110K | Buy |
2,853
+1,399
| +96% | +$53K | ﹤0.01% | 5809 |
|
|
2018
Q2 | $54K | Buy |
1,454
+537
| +59% | +$18.7K | ﹤0.01% | 6225 |
|
|
2018
Q1 | $26K | Sell |
917
-6,712
| -88% | -$225K | ﹤0.01% | 6597 |
|
|
2017
Q4 | $285K | Sell |
7,629
-1,504
| -16% | -$53.4K | ﹤0.01% | 4701 |
|
|
2017
Q3 | $344K | Buy |
9,133
+834
| +10% | +$26.2K | ﹤0.01% | 4494 |
|
|
2017
Q2 | $224K | Buy |
8,299
+4,531
| +120% | +$111K | ﹤0.01% | 4692 |
|
|
2017
Q1 | $74K | Sell |
3,768
-8,022
| -68% | -$148K | ﹤0.01% | 5431 |
|
|
2016
Q4 | $224K | Buy |
11,790
+7,704
| +189% | +$127K | ﹤0.01% | 5187 |
|
|
2016
Q3 | $67K | Buy |
4,086
+1,847
| +82% | +$29K | ﹤0.01% | 5466 |
|
|
2016
Q2 | $31K | Sell |
2,239
-5,763
| -72% | -$81.2K | ﹤0.01% | 5872 |
|
|
2016
Q1 | $124K | Buy |
8,002
+5,022
| +169% | +$73.6K | ﹤0.01% | 5505 |
|
|
2015
Q4 | $47K | Buy |
2,980
+2,978
| +148,900% | +$45.2K | ﹤0.01% | 5986 |
|
|
2015
Q3 | $0 | Sell |
2
-1,145
| -100% | -$15.2K | ﹤0.01% | 7596 |
|
|
2015
Q2 | $16K | Buy |
1,147
+603
| +111% | +$8.54K | ﹤0.01% | 6219 |
|
|
2015
Q1 | $8K | Sell |
544
-1,158
| -68% | -$16.4K | ﹤0.01% | 6553 |
|
|
2014
Q4 | $24K | Buy |
1,702
+1,355
| +390% | +$19.9K | ﹤0.01% | 6128 |
|
|
2014
Q3 | $5K | Buy |
347
+263
| +313% | +$3.62K | ﹤0.01% | 6561 |
|
|
2014
Q2 | $1K | Sell |
84
-5,722
| -99% | -$86.1K | ﹤0.01% | 6935 |
|
|
2014
Q1 | $96K | Buy |
5,806
+776
| +15% | +$13K | ﹤0.01% | 5029 |
|
|
2013
Q4 | $95K | Buy |
5,030
+3,949
| +365% | +$69.3K | ﹤0.01% | 5294 |
|
|
2013
Q3 | $20K | Sell |
1,081
-1,538
| -59% | -$26.4K | ﹤0.01% | 5913 |
|
|
2013
Q2 | $47K | Buy |
+2,619
| New | +$41.8K | ﹤0.01% | 5407 |
|
Other funds holding NRC
VCM
QI
Citigroup's NRC Position: Q1 2026 in Review
Citigroup increased its NRC Health Common Stock (NRC) stake by 116% in Q1 2026, buying an estimated $6.02K and bringing the position to 659 shares worth $11.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4992.
Citigroup first reported a position in NRC in Q2 2013 and has held it in 52 quarters since. The position peaked at $353K in Q2 2020. 121 funds tracked by Wall St. Rank hold NRC as of Q1 2026.
- Citigroup held 659 shares of NRC Health Common Stock worth $11.2K as of Q1 2026.
- Citigroup bought 354 NRC Health Common Stock shares in Q1 2026, an estimated $6.02K.
- NRC Health Common Stock made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #4992 holding.
- Citigroup first reported a position in NRC Health Common Stock in Q2 2013 and has held it in 52 quarters since.
- Citigroup's NRC Health Common Stock position peaked at $353K in Q2 2020.
- 121 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.